Profile
GCTK ISRG BDX ALC RMD WST
Company Name GlucoTrack, Inc. Intuitive Surgical, Inc. Becton, Dickinson and Company Alcon Inc. ResMed Inc. West Pharmaceutical Services, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies Medical - Instruments & Supplies
Market Cap $14.24M $175.06B $70.07B $48.19B $36.00B $22.75B
Employees 0.01K 13.68K 70.00K 25.00K 9.98K 10.60K
CEO Mr. Paul V. Goode Ph.D. Dr. Gary S. Guthart Ph.D. Mr. Thomas E. Polen Jr. Mr. David J. Endicott Mr. Michael J. Farrell BE, MBA, SM Mr. Eric M. Green
Ratings
GCTK ISRG BDX ALC RMD WST
Quant Rating Score 2 3 3 3 3 3
Quant Rating Sell Neutral Neutral Neutral Neutral Neutral
Trading
GCTK ISRG BDX ALC RMD WST
Last Close $2.5992 $492.63 $242.41 $97.68 $245.02 $313.63
High 52 $2.88 $492.63 $278.46 $97.68 $245.02 $413
Low 52 $0.15 $258.49 $221.47 $69.56 $134.65 $277.16
Price vs. 52 Week High -9.75 % 0 % -12.95 % 0 % 0 % -24.06 %
Price vs. 52 Week Low 1632.8 % 90.58 % 9.46 % 40.43 % 81.97 % 13.16 %
Total Return
GCTK ISRG BDX ALC RMD WST
1 Month Return 96.91 % 9.25 % 2.71 % 4.11 % 14.2 % 3.74 %
3 Month Return 12.03 % 22.51 % 4.5 % 9.59 % 18.75 % -5.36 %
6 Month Return 746.64 % 23.81 % 3.02 % 12.61 % 40.32 % -12.57 %
9 Month Return 796.28 % 56.29 % 1.75 % 28.8 % 53.48 % -10.85 %
YTD Return 893.96 % 46.03 % -0.58 % 25.04 % 42.44 % -10.93 %
1 Year Return 917.3 % 58.7 % -12.95 % 18.39 % 53.92 % -23.07 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
GCTK ISRG BDX ALC RMD WST
Dividend Yield Percentage (TTM) - - 1.55 % 0.27 % 0.8 % 0.26 %
Dividend Paid and Capex Coverage Ration (TTM) -128.73 % 1.16 % 2.18 % 2.05 % 3.53 % 1.66 %
Dividend Per Share (TTM) - - 3.76 % 0.26 % 1.97 % 0.8 %
Payout Ratio (TTM) - - 77.14 % 12.09 % 27.65 % 11.07 %
Growth
GCTK ISRG BDX ALC RMD WST
Asset Growth 101.19 % 19.02 % -0.29 % 1.35 % 1.79 % 5.88 %
Gross Profit Growth 43.48 % 12.71 % -3.62 % 18.11 % 10.75 % -0.62 %
Revenue Growth - 14.49 % 2.66 % 15.77 % 10.95 % 2.18 %
Revenue 3 Year - 63.36 % 10.28 % 46.5 % 44.86 % 36.66 %
Revenue 5 Year -100 % 85.79 % 9.38 % 39.86 % 74.97 % 70.83 %
Revenue 10 Year - 223.26 % 63.97 % 53.48 % 189.94 % 101.93 %
EBIT Growth -60.29 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Net Income Growth -59.91 % 35.98 % -16.58 % 190.75 % 13.75 % 1.28 %
Net Income 3 Yeari Growth Per Share -892.09 % 69.43 % 65.46 % 281.94 % 112.66 % 70.48 %
Net Income 5 Yeari Growth Per Share 83.56 % 54.83 % 330.62 % 525.33 % 145.63 % 185.26 %
Net Income 10 Yeari Growth Per Share 92.85 % 175.41 % -21.76 % 225.89 % 184.54 % 394.98 %
Operating Income Growth -60.29 % 45.86 % -7.49 % 87.58 % 22.29 % -7.9 %
Operating Cash Flow Growth (CFG) -75.86 % 21.67 % 13.52 % 21.73 % 102.11 % 7.25 %
Operating 3 Year CFG -580.29 % 22.09 % -17.7 % 78.55 % 87.99 % 63.45 %
Operating 5 Year CFG 79.15 % 50.62 % -5.85 % 28.82 % 197.13 % 167.61 %
Operating 10 Year CFG 79.89 % 111.85 % 35.21 % 11.44 % 244.62 % 229.88 %
EPS Growth -489.66 % 37.63 % -16.19 % 201.43 % 13.4 % 1.4 %
EPS Diluted Growth -489.66 % 37.81 % -15.99 % 198.57 % 13.63 % 1.94 %
Book Value Per Share 868.71 % 21.29 % 1.5 % 4.44 % 17.57 % 7.45 %
Share Holder 3 Year Equity Growth Per Share 29.27 % 36.28 % 5.73 % 8.65 % 66.6 % 54.52 %
Share Holder 5 Year Equity Growth Per Share 117.31 % 93.27 % 10.89 % -9.73 % 128.49 % 105.22 %
Share Holder 10 Year Equity Growth Per Share 102.85 % 290.63 % 248.77 % -13.54 % 166.2 % 197.74 %
Dividend Per Share Growth - - 2.5 % 19.49 % 9.12 % 5.5 %
Dividend 3 Year Growth Per Share - - 5.8 % - 23.08 % 17.87 %
Dividend 5 Year Growth Per Share - - 8.45 % - 29.8 % 34.66 %
Dividend 10 Year Growth Per Share -100 % - 96.74 % - 91.97 % 99.23 %
Debt Growth 0.51 % -4.26 % -1.16 % 1.48 % -44.68 % -2.8 %
Free Cash Flow Growth -75.82 % -21.79 % 27.41 % 21.44 % 130 % -5.67 %
Updated On 31 Dec 2023 31 Dec 2023 30 Sep 2023 31 Dec 2023 30 Jun 2024 31 Dec 2023
Profitability
GCTK ISRG BDX ALC RMD WST
Gross Profit Margin TTM -11.9 % 66.86 % 42.06 % 55.29 % 57.92 % 35.73 %
Return on Assets TTM -1250.82 % 12.57 % 2.54 % 3.71 % 14.86 % 15.04 %
Return on Equity TTM -513.94 % 15.36 % 5.51 % 5.34 % 22.41 % 19.08 %
Return on Capital Employed TTM 250.2 % 12.88 % 4.77 % 5.27 % 22.14 % 20.72 %
Net Income Per EBT TTM 100 % 93.85 % 84.46 % 106.81 % 80.72 % 85.87 %
EBT Per Ebit TTM 99.59 % 114.25 % 71.56 % 71.49 % 95.83 % 103.3 %
EBIT Per Revenue TTM -18180.95 % 25.79 % 11.79 % 14.76 % 29.03 % 20.57 %
Cash Flow To Debt Ratio TTM -4008.77 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Receivables Turnover TTM - 6.09 7.64 4.74 5.19 5.73
Payables Turnover TTM 0.02 12.91 2.31 5.04 8.05 8.73
Inventory Turnover TTM - 1.81 3.53 1.88 2.33 4.41
Fixed Asset Turnover TTM 26.75 % 183.94 % 304.2 % 208.76 % 650.22 % 175.95 %
Asset Turnover TTM 6.91 % 45.48 % 35.67 % 32.92 % 66.15 % 82.44 %
Operating Cash Flow Per Share TTM -1.67 4.05 13.62 3.77 9.54 10.31
Free Cash Flow Per Share TTM -1.68 0.54 11.13 2.2 8.76 4.89
Cash Per Share TTM 2.9 % 1340.06 % 1843.47 % 277.32 % 170.43 % 611.23 %
Operating Cash Flow Sales Ratio TTM -21761.9 % 18.96 % 19.9 % 19.09 % 30.82 % 26.15 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.78 % 13.43 % 81.67 % 58.41 % 91.8 % 47.46 %
Cash Flow Coverage Ratios TTM -4008.77 % 1671.71 % 20.42 % 39.25 % 191.3 % 331.45 %
Price To Free Cash Flows Ratio TTM -1.55 907.51 21.75 44.19 27.99 63.71
Price To Operating Cash Flows Ratio TTM -1.56 121.79 17.79 25.88 25.69 30.43
Price Cash Flow Ratio TTM -1.56 121.79 17.79 25.88 25.69 30.43
Income Statement (TTM)
GCTK ISRG BDX ALC RMD WST
Revenue $0B $7.12B $19.37B $10.09B $4.69B $2.95B
Gross Profit $-0B $4.73B $8.17B $5.61B $2.61B $1.13B
Gross Profit Ratio 0% 66.39% 42.17% 55.57% 55.68% 38.28%
EBITDA $-0.01B $2.19B $4.72B $2.56B $1.6B $0.88B
Net Income $-0.01B $1.8B $1.48B $0.97B $1.02B $0.59B
EPS Diluted -1.71 5.03 4.94 2.09 6.92 7.88
Balance Sheet (MRQ)
GCTK ISRG BDX ALC RMD WST
Long Term Debt $0B $-0.08B $14.74B $4.59B $0.7B $0.16B
Total Liabilities $0B $2.04B $26.98B $8.99B $2.01B $0.95B
Total Equity $0B $13.4B $25.8B $20.62B $4.86B $2.88B
Total Investments $0B $4.59B $0.01B $0.28B $0.17B $0.21B
Total Debt $0B $0.09B $15.88B $5.14B $0.87B $0.31B
Total Assets $0B $15.44B $52.78B $29.6B $6.87B $3.83B
Cash Flow Statement (TTM)
GCTK ISRG BDX ALC RMD WST
Net Income $-0.01B $1.82B $1.53B $1.04B $1.02B $0.59B
Inventory $0B $-0.71B $-0.02B $-0.29B $0.17B $-0.01B
Dividends Paid $0B $0B $-1.11B $-0.12B $-0.28B $-0.06B
Operating Cash Flow $-0.01B $1.81B $2.99B $1.48B $1.4B $0.78B
Capital Expenditure $0B $-1.06B $-0.87B $-0.91B $-0.11B $-0.36B
Related Stocks
Ticker Name Price
AKYA Akoya Biosciences, Inc. 2.55
ALC Alcon Inc. 97.68
ANGO AngioDynamics, Inc. 7.46
APR Apria, Inc. 37.5
ATR AptarGroup, Inc. 153.19
ATRC AtriCure, Inc. 26.21
ATRI Atrion Corporation 459.92
ATRS Antares Pharma, Inc. 5.59
AVGR Avinger, Inc. 1.11
AZTA Azenta, Inc. 49.52
BAX Baxter International Inc. 37.94
BDX Becton, Dickinson and Company 242.41
BDXB Becton, Dickinson and Company 48.16
BLCO Bausch + Lomb Corporation 16.43
BLFS BioLife Solutions, Inc. 25.88
COO The Cooper Companies, Inc. 105.73
DXR Daxor Corporation 8.4499
EKSO Ekso Bionics Holdings, Inc. 1.2
FEMY Femasys Inc. 1.17
GMVD G Medical Innovations Holdings Ltd 0.1835
Unlock